top of page

BUSINESS STRATEGY & INTERNATIONAL MARKETS

International pharmaceutical development requires a combination of scientific expertise, regulatory understanding, market knowledge and strong local partnerships.

OPES Healthcare works with partners across multiple markets to identify opportunities, develop appropriate business models and support the international growth of pharmaceutical products.

Our strategy is based on long-term cooperation rather than short-term transactions.

BUSINESS DEVELOPMENT

CREATING SUSTAINABLE OPPORTUNITIES

We work with pharmaceutical companies, distributors, licensing partners and other healthcare organisations seeking to expand their product portfolios or enter new markets.

Our business development activities include:

LICENSING

Opportunities for pharmaceutical product and technology licensing, including in-licensing and out-licensing arrangements where applicable.

​

CONTRACT MANUFACTURING

Manufacturing solutions designed around the requirements of pharmaceutical partners and individual projects.

​

TECHNOLOGY TRANSFER
Supporting the transfer and adaptation of pharmaceutical technologies and manufacturing processes.

​

DISTRIBUTION PARTNERSHIPS
Working with experienced local partners to develop commercial and distribution opportunities in selected markets.

​

REGULATORY & PRODUCT SUPPORT
Support for product documentation, registration activities and market requirements.

​

STRATEGIC PARTNERSHIPSBUILDING LONG-TERM RELATIONSHIPS AROUND SHARED PHARMACEUTICAL, TECHNOLOGICAL AND COMMERCIAL OBJECTIVES.

This integrated approach enables OPES Healthcare to work with partners at different stages of product development and commercialisation.

INTERNATIONAL MARKETS

GLOBAL REACH, LOCAL UNDERSTANDING

OPES Healthcare works with partners across a growing number of international markets.

​

Our international activities extend across Europe, CIS and Central Asia, Asia, Latin America and other regions.

Each market has its own regulatory framework, commercial environment and healthcare requirements. Our approach is therefore based on collaboration with local partners and an understanding of market-specific needs.

​

32+ COUNTRIES

Our products and partnerships extend across more than 32 international markets.

​

200+ TRADE PARTNERS

Our international network includes more than 200 trade partners.

INTERNATIONAL PARTNERSHIPS

BUILDING CONNECTIONS ACROSS MARKETS

We believe successful international expansion is built on strong local relationships.

​

Our partners provide valuable market knowledge, commercial expertise and local insight, while OPES contributes pharmaceutical products, technical capabilities and international experience.

​

Together, we create opportunities for sustainable market development.

UK & EUROPE

STRENGTHENING OUR INTERNATIONAL PRESENCE

We believe successful international expansion is built on strong local relationships.

​

Our partners provide valuable market knowledge, commercial expertise and local insight, while OPES contributes pharmaceutical products, technical capabilities and international experience.

​

Together, we create opportunities for sustainable market development.

ChatGPT Image Sep 22, 2026, 03_15_39 PM.jpg
bottom of page